Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$831M |
| 2 |
Palo Alto Networks
PANW
|
+$348M |
| 3 |
Visa
V
|
+$347M |
| 4 |
Citigroup
C
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$638M |
| 2 |
EOG Resources
EOG
|
+$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$289M |
| 5 |
JD.com
JD
|
+$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPPL
451
DELISTED
Columbia Pipeline Partners LP
CPPL
| $17.5M | 0.02% |
1,380,367
-1,692,526
| -55% | -$21.4M |
|
452
CommScope
COMM
$3.58B
| $17.4M | 0.02% |
+580,266
| New | +$17.4M |
|
453
Marcus & Millichap
MMI
$1.27B
| $17.3M | 0.02% |
376,084
-121,572
| -24% | -$5.59M |
|
|
CIM
454
Chimera Investment
CIM
$1.18B
| $16.8M | 0.02% |
418,539
+13,928
| +3% | +$559K |
|
|
ROIC
455
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $16.6M | 0.02% |
1,001,474
+290,972
| +41% | +$4.81M |
|
|
NXTM
456
DELISTED
NxStage Medical Inc.
NXTM
| $16.6M | 0.02% |
1,049,780
+112,792
| +12% | +$1.78M |
|
|
ITCI
457
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $16.1M | 0.02% |
+402,000
| New | +$16.1M |
|
458
Dorman Products
DORM
$4.98B
| $15.9M | 0.02% |
312,008
+297,770
| +2,091% | +$15.2M |
|
|
DWRE
459
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $15.8M | 0.02% |
+305,900
| New | +$15.8M |
|
460
IMAX
IMAX
$1.64B
| $15.8M | 0.02% |
467,414
+52,200
| +13% | +$1.76M |
|
|
GBT
461
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.6M | 0.02% |
+369,531
| New | +$15.6M |
|
|
NVRO
462
DELISTED
NEVRO CORP.
NVRO
| $15.1M | 0.02% |
326,410
+189,650
| +139% | +$8.8M |
|
463
BioCryst Pharmaceuticals
BCRX
$1.69B
| $15.1M | 0.02% |
1,324,549
+6,832
| +0.5% | +$77.9K |
|
|
KDNY
464
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.1M | 0.02% |
156,253
+6,273
| +4% | +$606K |
|
465
RPC Inc
RES
$1.04B
| $15.1M | 0.02% |
+1,703,339
| New | +$15.1M |
|
466
Dynavax Technologies
DVAX
$1.15B
| $15M | 0.02% |
+611,938
| New | +$15M |
|
467
United Natural Foods
UNFI
$1.72B
| $14.9M | 0.02% |
306,512
-10,364
| -3% | -$503K |
|
|
ZOES
468
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $14.8M | 0.02% |
375,347
-32,608
| -8% | -$1.29M |
|
469
Varonis Systems
VRNS
$6.41B
| $14.7M | 0.02% |
2,828,904
+696,252
| +33% | +$3.62M |
|
|
TSRO
470
DELISTED
TESARO, Inc.
TSRO
| $14.6M | 0.02% |
364,420
+111,746
| +44% | +$4.48M |
|
471
Kosmos Energy
KOS
$794M
| $14.6M | 0.02% |
2,616,231
+36,749
| +1% | +$205K |
|
|
B
472
DELISTED
Barnes Group Inc.
B
| $14.3M | 0.01% |
+397,807
| New | +$14.3M |
|
|
PRTY
473
DELISTED
Party City Holdco Inc.
PRTY
| $14.2M | 0.01% |
891,933
+465,692
| +109% | +$7.44M |
|
474
ProQR Therapeutics
PRQR
$239M
| $14.1M | 0.01% |
968,755
+2,322
| +0.2% | +$33.8K |
|
|
PKY
475
DELISTED
Parkway, Inc.
PKY
| $14.1M | 0.01% |
907,159
-161,648
| -15% | -$2.52M |
|